Jason Meyenburg

Directeur Général chez Gemini Therapeutics Sub, Inc.

Profil

Jason Meyenburg currently works at Gemini Therapeutics Sub, Inc., as Chief Executive Officer & Director from 2019.
Mr. Meyenburg also formerly worked at Auregen Biotherapeutics SA, as Chief Executive Officer, Gemini Therapeutics, Inc., as President, Chief Executive Officer & Director, Alexion Pharmaceuticals, Inc., as Senior Vice President-Commercial Operations from 2003 to 2016, Sucampo Pharmaceuticals LLC, as Chief Commercial Officer from 2017 to 2018, Alexion Pharma GmbH, as Vice President-Commercial Operations from 2010 to 2014, Vtesse, Inc., as Chief Commercial Officer from 2016 to 2017, and Orchard Therapeutics Plc, as Chief Commercial Officer from 2018 to 2019.
Mr. Meyenburg received his undergraduate degree from the University of Maryland and Masters Business Admin degree from The Fuqua School of Business.

Postes actifs de Jason Meyenburg

Sociétés	Poste	Début
Gemini Therapeutics Sub, Inc.	Directeur Général	13/09/2019

Anciens postes connus de Jason Meyenburg

Sociétés	Poste	Fin
GEMI THER	Directeur Général	28/02/2022
ORCHARD THERAPEUTICS PLC	Corporate Officer/Principal	13/09/2019
SUCAMPO PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/03/2018
Vtesse, Inc.	Corporate Officer/Principal	01/04/2017
ALEXION PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/02/2016